EUVIMEDTutustu EUVIMEDiin
Crossref

Impact of Restrictive Cardiac Allograft Physiology on Heart Re‐Transplantation Outcomes

Masaki Tsuji iD, Jignesh K Patel, Michelle M Kittleson iD, David H Chang, Evan P Kransdorf iD, Andriana P Nikolova, Lily K Stern iD, Mason Lee, Jon A Kobashigawa

Clinical Transplantation · 2025

DOI: 10.1111/ctr.70124 ↗

At a glance

Journal article in Clinical Transplantation, 2025. Written by Masaki Tsuji and 8 co-authors. Institution: Department of Cardiology, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA. Major MEDLINE topics: Heart Transplantation, Graft Rejection, Reoperation, Postoperative Complications. 29 references. Funded by: Mochida Memorial Foundation for Medical and Pharmaceutical Research.

TiivistelmäSubjectsBibliografiset tiedotCiteRelated studies

Abstract (original language)

Background

Heart re‐transplantation (re‐HT) is the last treatment option for end‐stage graft failure, with cases due to severe cardiac allograft vasculopathy (CAV) showing a better prognosis compared to other indications. However, the effects of restrictive cardiac allograft physiology (RCP), classified as severe CAV, on re‐HT outcomes remain unclear.

Methods

We assessed patients with severe CAV who underwent re‐HT between 2010 and 2024. RCP was defined as symptomatic heart failure with restrictive echocardiographic values (E‐to‐A velocity ratio >2 and deceleration time 12 mmHg, pulmonary capillary wedge pressure >25 mmHg, and cardiac index

Subjects

MeSH terms (MEDLINE)

Heart TransplantationGraft RejectionReoperationPostoperative ComplicationsHeart FailureHumansFemaleMaleMiddle AgedPrognosisFollow-Up StudiesRetrospective StudiesSurvival RateGraft SurvivalRisk FactorsAllograftsAdult

Authors and institutions

  • Department of Cardiology, Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA.

ORCID profiles: Masaki Tsuji, Michelle M Kittleson, Evan P Kransdorf, Lily K Stern

Funding

  • Mochida Memorial Foundation for Medical and Pharmaceutical Research

Cite

APA

Tsuji, M., Patel, J. K., Kittleson, M. M., Chang, D. H., Kransdorf, E. P., Nikolova, A. P., Stern, L. K., Lee, M., & Kobashigawa, J. A. (2025). Impact of Restrictive Cardiac Allograft Physiology on Heart Re‐Transplantation Outcomes. Clinical Transplantation. https://doi.org/10.1111/ctr.70124

Vancouver

Tsuji M, Patel JK, Kittleson MM, Chang DH, Kransdorf EP, Nikolova AP, et al. Impact of Restrictive Cardiac Allograft Physiology on Heart Re‐Transplantation Outcomes. Clinical Transplantation. 2025. doi:10.1111/ctr.70124

BibTeX
@article{Tsuji2025,
  author = {Tsuji, Masaki and Patel, Jignesh K and Kittleson, Michelle M and Chang, David H and Kransdorf, Evan P and Nikolova, Andriana P and Stern, Lily K and Lee, Mason and Kobashigawa, Jon A},
  title = {Impact of Restrictive Cardiac Allograft Physiology on Heart Re‐Transplantation Outcomes},
  journal = {Clinical Transplantation},
  year = {2025},
  doi = {10.1111/ctr.70124}
}
Start for free →